TTEN·K/calls
Pinned
  • The Brief
  • Congress
  • Screener
  • Markets
  • The Brief
  • Signal Confluence
  • The Flip Side
  • Markets
  • Calendar
  • Coverage
  • Screener
  • Discover
  • Smart Money
  • Congress
  • Insiders
  • IPOs
  • 13F Funds
  • Events
  • Filings
  • News
  • Trending
  • Groups
  • Data catalog
  • Research
  • Education
  • Options Plays
  • Options Calculator
  • Leaderboards
  • Compare
  • Portfolio
  • Strategies
  • Track
  • Pricing
  • API
  • Newsletter
  • Follow the calls
  • Feedback
  • Account
Go ProUpgrade →
TTEN·K/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Telegram ↗X ↗Bluesky ↗Follow the calls →

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

MethodologyDisclosuresTermsPrivacy

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

← New search
Home›Coverage›MESO
On this page
OverviewValuationQualitySmart moneyFilings
MESO logo

MESOMESOBLAST LTD

Next earnings Aug 26, 2026 (after close) · consensus $-0.11 EPS, $66.7M rev

Sell
$15.44
▲ +4.11%
Rating
Sell
Quality
C
Valuation
Fair value
How to read this →
SellMixed signals in the latest filings.Full call ↓
$15.44▲ +46.63%
over 1Y
L $10.45H $20.96
Today
+4.1%
1W
+7.7%
1M
+11.9%
3M
+2.9%
YTD
-15.0%
1Y
+46.6%
OverviewValuationQualitySmart moneyFilings
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 10 analysts
Buy

Mixed signals in the latest filings.

This call stands until the filings change it — the engine re-rates on new 10-K/10-Q/8-K facts, never on price moves. Hit Watch above to follow MESO (Pro alerts fire the moment a rating flips), or catch every change in Saturday’s Flip Side. How to read a call

MESOBLAST LTD shows limited reported revenue.

On these fundamentals, MESO screens as SELL on the SEC figures.

Is MESO a buy? The one-page verdict, explained →

The options angle

model · matches our verdict
Bear put spread~60d expiry
  • Long put 15.5 @ ~1.46 est
  • Short put 14 @ ~0.77 est
debit $69max +$81max −$69BE 14.81

SELL verdict, defined risk: profits into weakness down to the short strike; max loss is the net debit.

Open in the calculator →
Browse all model plays →

Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.

Financialsannual, by fiscal year

No income data filed.

10-year statements — income, cash flow, balance sheet & CSV export →

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value$1.92B
EV / EBITDA—
EV / Sales—
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield—
FCF yield—

Quality & risk

ROIC (est.)—
Free cash flow—
Total debt$5.02M
Net cash—

Capital returns

Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+12.1%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Recent filings

all on EDGAR ↗
6-KPeriod ending 2026-07-102026-07-10open ↗4Period ending 2026-07-072026-07-09open ↗6-KPeriod ending 2026-07-012026-07-01open ↗6-KPeriod ending 2026-06-252026-06-25open ↗6-KPeriod ending 2026-06-102026-06-10open ↗6-KPeriod ending 2026-04-302026-04-30open ↗3Period ending 2026-03-182026-04-29open ↗6-KPeriod ending 2026-04-292026-04-29open ↗6-KPeriod ending 2026-04-172026-04-17open ↗6-KPeriod ending 2026-04-152026-04-15open ↗4Period ending 2026-04-092026-04-13open ↗4Period ending 2026-04-092026-04-10open ↗

Quality score

C
ValueGrowthProfitHealthMom.
Value—
Growth—
Profitability—
Financial health—
MomentumC
10.9652-week20.96
Revenue
—
Net margin
—
ROE
—
P/E
—

SEC fundamentals · FY 2022

Frequently asked

Is MESOBLAST LTD (MESO) a buy?
MESO currently carries a Sell rating with 2/5 conviction, derived from its latest SEC filings. Mixed signals in the latest filings.
What is MESOBLAST LTD's quality score?
MESO scores 55.47328388401887/100 (grade C) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001345099, latest 6-K filed 2026-07-10) · EODHD · as of 7/11/2026, 9:54:02 AM.

›About this recommendation — produced by TENK/calls (tenkcalls.com), Luxembourg · not investment advice

Rule-based analysis, generated automatically from SEC filing data.

Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 11, 2026, 5:54 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Intraday
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%LLY$1,188.58▼2.33%BRK-B$493.71▼0.35%BRK-A$739,750.00▼0.17%JPM$336.47▲0.30%WMT$113.90▲1.51%AMD$557.89▲2.04%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%LRCX$350.33▼0.80%ABBV$248.08▼0.73%CAT$952.41▲1.49%BAC$59.67▲0.71%
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%LLY$1,188.58▼2.33%BRK-B$493.71▼0.35%BRK-A$739,750.00▼0.17%JPM$336.47▲0.30%WMT$113.90▲1.51%AMD$557.89▲2.04%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%LRCX$350.33▼0.80%ABBV$248.08▼0.73%CAT$952.41▲1.49%BAC$59.67▲0.71%
Intraday
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%LLY$1,188.58▼2.33%BRK-B$493.71▼0.35%BRK-A$739,750.00▼0.17%JPM$336.47▲0.30%WMT$113.90▲1.51%AMD$557.89▲2.04%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%LRCX$350.33▼0.80%ABBV$248.08▼0.73%CAT$952.41▲1.49%BAC$59.67▲0.71%
NVDA$210.96▲4.03%AAPL$315.32▼0.28%GOOGL$357.18▼0.48%GOOG$355.03▼0.34%MSFT$385.10▲0.19%AMZN$245.34▼0.69%TSM$434.11▼0.65%SPCX$145.30▼4.51%AVGO$399.97▼0.28%META$669.21▲5.97%TSLA$407.76▲0.30%MU$979.30▼1.24%LLY$1,188.58▼2.33%BRK-B$493.71▼0.35%BRK-A$739,750.00▼0.17%JPM$336.47▲0.30%WMT$113.90▲1.51%AMD$557.89▲2.04%ASML$1,797.32▼0.38%V$348.97▲0.22%JNJ$256.98▼0.82%XOM$138.88▲1.03%INTC$109.84▼2.40%AMAT$602.50▲2.35%CSCO$121.31▲2.54%MA$526.74▲0.68%LRCX$350.33▼0.80%ABBV$248.08▼0.73%CAT$952.41▲1.49%BAC$59.67▲0.71%

Insider activityForm 4 · SEC

all insiders →
2026-04-10
George Gregory
Director
Buy
2.32M @ $1.48$3.44M
2026-04-10
George Gregory
Director
Buy
2.32M @ $1.48$3.44M
2026-04-09
George Gregory
Director
Buy
887K @ $1.43$1.27M
2026-04-09
George Gregory
Director
Buy
105K @ $1.46$153K
2026-04-09
George Gregory
Director
Buy
500K @ $1.44$720K
2026-04-09
George Gregory
Director
Buy
10.0K @ $1.44$14.4K
2026-04-09
George Gregory
Director
Buy
4.76K @ $1.44$6.85K
2026-04-09
George Gregory
Director
Buy
20.0K @ $1.43$28.6K
2026-04-09
George Gregory
Director
Buy
10.0K @ $1.43$14.3K
2026-04-09
George Gregory
Director
Buy
5.24K @ $1.43$7.49K
2026-04-09
George Gregory
Director
Buy
10.0K @ $1.43$14.3K
2026-04-09
George Gregory
Director
Buy
5.00K @ $1.43$7.15K

ETF ownershipForm N-PORT · SEC · quarterly

IBBiShares Biotechnology ETF0.09%$7.08M

Weight = the ETF’s percent of assets in MESO, as of each fund’s latest public N-PORT (period end 2026-03-31) — a delayed, roughly quarterly snapshot filed ~2 months after the period, not a live position.

Ownership stakes

SEC · 13D / 13G
2026-03-11Passive 13G22.4%AmendedGeorge GregoryFiling ↗

Schedule 13D/13G filings disclosing a >5% stake in the company. A 13D declares intent to engage — read the filing; a 13G is a passive holding. Percent is the percent-of-class stated on the cover page. Source: SEC EDGAR (public domain).

Fails-to-deliver

SEC · settled 2026-06-12
3.31Kshares failed to deliver1.5× median

Aggregate CNS settlement fails on the latest published day, vs this name’s trailing median. From SEC fails-to-deliver data (published twice monthly) — a settlement metric, not short interest.

SEC correspondence

SEC · UPLOAD / CORRESP
2026-01-12Company responseCORRESPFiling ↗
2026-01-05SEC letterUPLOADFiling ↗
2025-02-10Company responseCORRESPFiling ↗
2025-02-07SEC letterUPLOADFiling ↗

SEC staff comment letters (UPLOAD) questioning the company’s disclosures and its written responses (CORRESP), from the SEC’s filing review. Reviews are routine and this is not an assertion of wrongdoing; correspondence is released about 20 business days after a review concludes, so dates reflect the letter itself, not its release. Source: SEC EDGAR (public domain).

Recent news

market news →
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Amid Renewed US-Iran Tensions Ahead of Q2 Earnings SeasonBullish
finance.yahoo.com· 2026-07-10
Ryoncil® Delivers Net Revenue of US$36M for the Fourth Quarter Ended 30 June 2026Bullish
finance.yahoo.com· 2026-07-10
Ryoncil® Delivers Net Revenue of US$36M for the Fourth Quarter Ended 30 June 2026Bullish
globenewswire.com· 2026-07-10
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADsBullish
finance.yahoo.com· 2026-07-01
Mesoblast Receives BLA Filing Number and Requests Modular Review for Rexlemestrocel-L in Patients with End-Stage Heart Failure and LVADsBullish
globenewswire.com· 2026-07-01
Mesoblast Draws US$50 Million from Five-Year Non-Dilutive FacilityBullish
finance.yahoo.com· 2026-06-25

Vs tracked universe

compare →

1184 tracked peers · median

TENK Score55 vs 67
Revenue growth— vs 7.6%
Net margin— vs 10.0%
Return on equity— vs 12.0%
P/E— vs 26.5

News sentiment

EODHD · 5d
Bullish
+0.18
vs typical · 8 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.